The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Quest Diagnostics, Inc shares valued at $365,375 were sold by Plewman Patrick on Aug 21 ’25. At $185.00 per share, Plewman Patrick sold 1,975 shares. The insider’s holdings dropped to 15,269 shares worth approximately $2.75 million following the completion of this transaction.
Also, Plewman Patrick sold 4,532 shares, netting a total of over 829,356 in proceeds. Following the sale of shares at $183.00 each, the insider now holds 17,244 shares.
Before that, Plewman Patrick had added 1,975 shares to its account. In a trade valued at $365,375, the Officer bought Quest Diagnostics, Inc shares for $185.00 each.
As published in a research note from Robert W. Baird on August 25, 2025, Quest Diagnostics, Inc [DGX] has been rated down from an Outperform to a Neutral and the price target has been revised to $194. Analysts at Redburn Atlantic started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of March 04, 2025, Citigroup has decreased its “Buy” rating to a “Neutral” for DGX. Earlier on January 06, 2025, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for DGX stock which previously was a “a Market perform”.
Analyzing DGX Stock Performance
On last trading session, Quest Diagnostics, Inc [NYSE: DGX] plunged -1.39% to $180.14. The stock’s lowest price that day was $179.77, but it reached a high of $182.11 in the same session. During the last five days, there has been a surge of approximately 0.35%. Over the course of the year, Quest Diagnostics, Inc shares have jumped approximately 17.79%. Shares of the company reached a 52-week high of $185.62 on 08/22/25 and a 52-week low of $148.70 on 01/16/25.
Support And Resistance Levels for Quest Diagnostics, Inc (DGX)
According to the 24-hour chart, there is a support level at 179.24, which, if violated, would cause prices to drop to 178.33. In the upper region, resistance lies at 181.58. The next price resistance is at 183.01. RSI (Relative Strength Index) is 52.49 on the 14-day chart, showing neutral technical sentiment.
Is Quest Diagnostics, Inc subject to short interest?
Stocks of Quest Diagnostics, Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.54 million shares to 4.03 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 4.58 million shares. A decline of -13.49% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.2 of the overall float, the days-to-cover ratio (short ratio) decline to 3.2.
Which companies own the most shares of Quest Diagnostics, Inc (DGX)?
In terms of Quest Diagnostics, Inc share price expectations, FactSet research, analysts set an average price target of 194 in the next 12 months, up nearly 6.2% from the previous closing price of $182.68. Analysts anticipate Quest Diagnostics, Inc stock to reach 195 by 2025, with the lowest price target being 185. In spite of this, 10 analysts ranked Quest Diagnostics, Inc stock as Buy at the end of 2025. On December 17, 2024, Morgan Stanley assigned a price target of “an Overweight” to the stock and upgraded coverage with a $172.
